KRAS and cancer: For instance, in KRAS-dependent mutant cancer, dual knockout of RhoA/Rho kinase (ROCK) and polp-like kinase-1 by siRNA enhanced the expression of the cyclin-dependent kinase, which ultimately impaired the growth of KRAS-mutant cells’ proliferation [18].